On February 27, 2024, the Board appointed former director, Frederick D. Hrkac as a director, president and principal executive officer of the Company, effective as of February 27, 2024 (the ?Effective Date?), to serve for a term expiring at the next annual meeting of the Company?s stockholders or until his successor is duly elected and qualified, or his earlier death, resignation or removal. There are no arrangements or understandings between Mr. Hrkac and any other person pursuant to which Mr. Hrkac was selected as a director. There are no transactions in which Mr. Hrkac has an interest requiring disclosure under item 404(a) of Regulation S-K. Kenneth L. Londoner resigned from his positions as director, executive chairman and chief executive officer of BioSig Technologies, Inc. (the ?Company?) and from any and all committees, offices, appointments, designations, responsibilities or other capacities related to the Company or any of its subsidiaries, effective as of the Effective Date.

Mr. Londoner?s resignation was not the result of any disagreement regarding any matter relating to the Company?s operations, policies or practices.